94 related articles for article (PubMed ID: 28456727)
21. Investigation on the interaction of Rutin with serum albumins: Insights from spectroscopic and molecular docking techniques.
Sengupta P; Sardar PS; Roy P; Dasgupta S; Bose A
J Photochem Photobiol B; 2018 Jun; 183():101-110. PubMed ID: 29702339
[TBL] [Abstract][Full Text] [Related]
22. Is the Sudlow site I of human serum albumin more generous to adopt prospective anti-cancer bioorganic compound than that of bovine: A combined spectroscopic and docking simulation approach.
Joshi R; Jadhao M; Kumar H; Ghosh SK
Bioorg Chem; 2017 Dec; 75():332-346. PubMed ID: 29096094
[TBL] [Abstract][Full Text] [Related]
23. Ion-specific electrode study of copper binding to serum albumins.
Mohanakrishnan P; Chignell CF
J Pharm Sci; 1982 Oct; 71(10):1180-2. PubMed ID: 7143222
[TBL] [Abstract][Full Text] [Related]
24. In vitro binding of 14C-labeled acidic compounds to serum albumin and their tissue distribution in the rat.
Fang SC; Lindstrom FT
J Pharmacokinet Biopharm; 1980 Dec; 8(6):583-97. PubMed ID: 7229910
[TBL] [Abstract][Full Text] [Related]
25. Interaction of Citrinin with Human Serum Albumin.
Poór M; Lemli B; Bálint M; Hetényi C; Sali N; Kőszegi T; Kunsági-Máté S
Toxins (Basel); 2015 Dec; 7(12):5155-66. PubMed ID: 26633504
[TBL] [Abstract][Full Text] [Related]
26. Molecular structure-affinity relationship of bufadienolides and human serum albumin in vitro and molecular docking analysis.
Zhou J; Lu G; Wang H; Zhang J; Duan J; Ma H; Wu Q
PLoS One; 2015; 10(5):e0126669. PubMed ID: 25946161
[TBL] [Abstract][Full Text] [Related]
27. Binding of an anticancer drug, axitinib to human serum albumin: Fluorescence quenching and molecular docking study.
Tayyab S; Izzudin MM; Kabir MZ; Feroz SR; Tee WV; Mohamad SB; Alias Z
J Photochem Photobiol B; 2016 Sep; 162():386-394. PubMed ID: 27424099
[TBL] [Abstract][Full Text] [Related]
28. An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
De Las Heras J; Aldámiz-Echevarría L; Martínez-Chantar ML; Delgado TC
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):439-448. PubMed ID: 27860485
[TBL] [Abstract][Full Text] [Related]
29. (EZ)-Cyclobilirubin formation from bilirubin in complex with serum albumin derived from various species.
Iwase T; Kusaka T; Itoh S
J Photochem Photobiol B; 2010 Feb; 98(2):138-43. PubMed ID: 20047841
[TBL] [Abstract][Full Text] [Related]
30. Exploring the interaction between Salvia miltiorrhiza and human serum albumin: Insights from herb-drug interaction reports, computational analysis and experimental studies.
Shao X; Ai N; Xu D; Fan X
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():1-7. PubMed ID: 26926393
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders.
Monteleone JP; Mokhtarani M; Diaz GA; Rhead W; Lichter-Konecki U; Berry SA; Lemons C; Dickinson K; Coakley D; Lee B; Scharschmidt BF
J Clin Pharmacol; 2013 Jul; 53(7):699-710. PubMed ID: 23775211
[TBL] [Abstract][Full Text] [Related]
32. Binding of thioflavin T by albumins: An underestimated role of protein oligomeric heterogeneity.
Rovnyagina NR; Sluchanko NN; Tikhonova TN; Fadeev VV; Litskevich AY; Maskevich AA; Shirshin EA
Int J Biol Macromol; 2018 Mar; 108():284-290. PubMed ID: 29208556
[TBL] [Abstract][Full Text] [Related]
33. Interactions of perfluorooctanoic acid and perfluorooctanesulfonic acid with serum albumins by native mass spectrometry, fluorescence and molecular docking.
Chi Q; Li Z; Huang J; Ma J; Wang X
Chemosphere; 2018 May; 198():442-449. PubMed ID: 29425944
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the antioxidant activity of albumin from various animal species.
Okazaki T; Okudaira N; Ishii N; Yotsuyanagi H; Nagai T; Tokudome S; Fujioka T; Takahashi S
Zoolog Sci; 2008 Feb; 25(2):172-7. PubMed ID: 18533748
[TBL] [Abstract][Full Text] [Related]
35. The binding of novel two-color fluorescence probe FA to serum albumins of different species.
Ercelen S; Klymchenko AS; Mély Y; Demchenko AP
Int J Biol Macromol; 2005 Jun; 35(5):231-42. PubMed ID: 15862861
[TBL] [Abstract][Full Text] [Related]
36. Association equilibrium of L-methamphetamine with serum albumin in various animal species.
Yanagisawa Y; Nakazato KI; Nagai T
Pharmacol Res; 1997 Apr; 35(4):341-5. PubMed ID: 9264052
[TBL] [Abstract][Full Text] [Related]
37. Risperidone interacts with serum albumin forming complex.
Fragoso VM; Silva D; Cruz FA; Cortez CM
Environ Toxicol Pharmacol; 2012 Mar; 33(2):262-6. PubMed ID: 22245842
[TBL] [Abstract][Full Text] [Related]
38. Modulated photophysics of a cationic DNA-staining dye inside protein bovine serum albumin: study of binding interaction and structural changes of protein.
Samanta A; Jana S; Ray D; Guchhait N
Spectrochim Acta A Mol Biomol Spectrosc; 2014; 121():23-34. PubMed ID: 24216153
[TBL] [Abstract][Full Text] [Related]
39. Crystallographic studies of the complexes of bovine and equine serum albumin with 3,5-diiodosalicylic acid.
Sekula B; Zielinski K; Bujacz A
Int J Biol Macromol; 2013 Sep; 60():316-24. PubMed ID: 23769932
[TBL] [Abstract][Full Text] [Related]
40. Perceptions and use of phenylbutyrate metabolite testing in urea cycle disorders: Results of a clinician survey and analysis of a centralized testing database.
Ficicioglu C; Liu N; Sun Q; Burdett A; Hata A; Porter M; Sutton VR
Mol Genet Metab; 2022 Jan; 135(1):35-41. PubMed ID: 34980542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
